Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
SCH54292
Cat. No.:
OB0225LY-0077
Appearance:
Solid
Purity:
≥95%
Identity:
Confirmed by NMR and HPLC.
Size:
Product Overview
Description:
SCH54292 is a GDP exchange inhibitor with anti-tumor activity and belongs to the class of small molecule drugs. Its mechanism of action is mainly to interfere with the growth and survival of cancer cells by inhibiting specific enzymes.
Synonym:
188480-51-5; 4-(Hydroxyamino)-N-(2-(naphthalen-2-yloxy)ethyl)-N-((2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)benzenesulfonamide; Benzenesulfonamide, N-beta-D-glucopyranosyl-4-(hydroxyamino)-N-[2-(2-naphthalenyloxy)ethyl]-; 4-(Hydroxyamino)-N-(2-naphthalen-2-yloxyethyl)-N-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]benzenesulfonamide
CAS No.:
188480-51-5
Compound CID:
16082414
Formula:
C24H28N2O9S
Formula Weight:
520.55
Specification
Relative Density:
1.58 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
SCH54292 can be used for drug discovery.
Library Information
Targets:
Ras
Pathways:
MAPK; GPCR/G protein
Plate Number:
AOCL-1
Plate Location:
h10
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
55 mg/ml; 105.66 mM
